BIOCELL

Scope & Guideline

Advancing the Frontiers of Cell Biology

Introduction

Welcome to your portal for understanding BIOCELL, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN0327-9545
PublisherTECH SCIENCE PRESS
Support Open AccessNo
CountryArgentina
TypeJournal
Convergefrom 1995 to 2013, from 2015 to 2024
AbbreviationBIOCELL / Biocell
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address871 CORONADO CENTER DR, SUTE 200, HENDERSON, NV 89052

Aims and Scopes

BIOCELL is a journal dedicated to the exploration of cellular and molecular biology, emphasizing the interplay between biological systems and their microenvironments. The journal aims to publish high-quality research that elucidates mechanisms underlying cellular functions, disease processes, and therapeutic interventions.
  1. Cellular and Molecular Mechanisms:
    Research articles focusing on the intricate cellular pathways and molecular mechanisms that govern various biological processes, including cell proliferation, differentiation, apoptosis, and autophagy.
  2. Stem Cell Biology and Regenerative Medicine:
    A significant focus on the properties, applications, and therapeutic potentials of stem cells, including their roles in tissue engineering, regeneration, and treatment of various diseases.
  3. Cancer Biology and Therapeutics:
    Investigations into the molecular and cellular underpinnings of cancer, including tumor microenvironment interactions, cancer stem cells, and novel therapeutic approaches.
  4. Immunology and Host-Pathogen Interactions:
    Studies that explore the immune response to pathogens, the mechanisms of immune evasion by cancer cells, and the development of immunotherapies.
  5. Bioinformatics and Systems Biology:
    Utilization of computational methods and bioinformatics tools to analyze large datasets, identify biomarkers, and understand complex biological interactions.
  6. Nanotechnology and Biomaterials:
    Research highlighting the application of nanomaterials and biomaterials in biological systems, particularly in drug delivery, diagnostics, and tissue engineering.
BIOCELL has been progressively embracing emerging trends in research, reflecting the dynamic nature of the fields of cellular and molecular biology. The following themes have gained significant traction in recent publications.
  1. Single-Cell Sequencing and Transcriptomics:
    There is a marked increase in studies utilizing single-cell sequencing technologies to explore cellular heterogeneity and gene expression profiles, particularly in cancer and immune responses.
  2. Microbiome and Host Interactions:
    Research exploring the gut microbiome's influence on health and disease, including its interactions with host cells and implications for personalized medicine, has emerged as a key area of interest.
  3. Advancements in Nanotechnology:
    The application of nanotechnology in drug delivery systems, diagnostics, and therapeutic interventions is increasingly prominent, reflecting the journal's commitment to cutting-edge research.
  4. Cancer Immunotherapy:
    A growing body of work focuses on cancer immunotherapy, including the mechanisms of immune evasion and the development of novel immunotherapeutic strategies.
  5. Epigenetic Modifications in Health and Disease:
    There is an increasing emphasis on studies investigating the role of epigenetic changes in various diseases, including cancer and metabolic disorders, highlighting their potential as therapeutic targets.
  6. Biomaterials for Tissue Engineering:
    Research on innovative biomaterials for tissue engineering applications is gaining momentum, particularly those that enhance cellular interactions and promote regeneration.

Declining or Waning

While BIOCELL has consistently focused on several core areas, certain themes appear to be waning in prominence as the journal evolves to address emerging scientific challenges and innovations.
  1. Traditional Pharmacological Studies:
    There seems to be a decline in publications centered on classical pharmacological approaches, as the journal shifts towards more innovative and integrative methodologies.
  2. In vitro Models with Limited Relevance:
    Research utilizing simplistic in vitro models that do not adequately mimic the complexity of in vivo systems appears to be decreasing, as the field moves towards more sophisticated models, including organ-on-a-chip technologies.
  3. Basic Plant Biology Studies:
    While still relevant, there is a noticeable reduction in the number of studies solely focused on fundamental plant biology, as the journal pivots towards translational research and applications in human health.
  4. Non-targeted Metabolomics:
    The focus on non-targeted metabolomics studies has diminished, likely due to the growing emphasis on targeted approaches that yield more actionable insights in therapeutic contexts.
  5. Animal Studies with Limited Clinical Relevance:
    Research involving animal models that do not translate well to human conditions is less frequently published, reflecting a trend towards studies that emphasize translational potential.

Similar Journals

Cell Stem Cell

Pioneering Insights in Cellular Biology and Regenerative Medicine
Publisher: CELL PRESSISSN: 1934-5909Frequency: 12 issues/year

Cell Stem Cell, published by CELL PRESS, is a premier journal at the forefront of cellular biology, genetics, and molecular medicine. With an esteemed impact factor and recognized as a Q1 journal in multiple categories including Cell Biology, Genetics, and Molecular Medicine, it offers researchers, professionals, and students rigorous, peer-reviewed articles that shape the future of stem cell research and regenerative medicine. Located in Cambridge, MA, this journal has become an invaluable resource since its inception in 2007 and is committed to disseminating groundbreaking findings that drive innovation and understanding in these critical fields. By consistently ranking within the top percentile of its categories in Scopus, Cell Stem Cell remains an essential platform for scholarly communication, fostering collaboration among leading scientists worldwide. Although the journal does not currently offer open access options, its comprehensive insights are pivotal for anyone engaged in the study of stem cells and their applications.

Cellular and Molecular Bioengineering

Unleashing Potential: Where Molecular Biology Meets Engineering
Publisher: SPRINGERISSN: 1865-5025Frequency: 4 issues/year

Cellular and Molecular Bioengineering, published by SPRINGER, is a prominent journal dedicated to the exploration of interdisciplinary approaches in the fields of biochemistry, genetics, and molecular biology. With an ISSN of 1865-5025 and an E-ISSN of 1865-5033, this journal has been a pivotal resource since its inception in 2009, showcasing groundbreaking research that combines innovative modeling and simulation techniques with cellular and molecular applications. As a Q2 journal in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Modeling and Simulation categories, it ranks favorably in the Scopus metrics, placing 62nd out of 324 in Mathematics_ Modeling and Simulation, and 69th out of 221 in General Biochemistry, Genetics and Molecular Biology. The journal's commitment to quality research and its contribution to advancing academic dialogue make it essential for researchers, professionals, and students seeking to stay at the forefront of bioengineering innovation. While it currently does not offer open access, it continues to provide significant insights and empirical studies that can help shape future developments in the field, reinforcing its role as a key player in cellular and molecular bioengineering.

CELL DEATH AND DIFFERENTIATION

Exploring the Frontiers of Cellular Dynamics
Publisher: SPRINGERNATUREISSN: 1350-9047Frequency: 12 issues/year

CELL DEATH AND DIFFERENTIATION, published by SpringerNature, is a leading peer-reviewed journal that has been at the forefront of advancing knowledge in the fields of cell biology and molecular biology since its inception in 1994. With an impressive impact factor and ranking in the Q1 quartile for both categories as of 2023, it is recognized as an essential resource for researchers and professionals dedicated to understanding the intricate processes of cellular death and differentiation. The journal publishes high-quality original research articles, reviews, and commentaries, fostering an interdisciplinary dialogue among scientists exploring the molecular mechanisms that underpin these fundamental biological processes. With its commitment to excellence, CEL DEATH AND DIFFERENTIATION bridges gaps in knowledge and stimulates innovation within the scientific community. To access cutting-edge research from this prestigious journal, you may visit their website for subscription options and explore a wealth of knowledge that is crucial for advancing the frontiers of biological research.

International Journal of Molecular and Cellular Medicine

Elevating Understanding in Molecular and Cellular Medicine
Publisher: CELLULAR & MOLECULAR BIOLOGY RESEARCH CENTERISSN: 2251-9637Frequency: 4 issues/year

International Journal of Molecular and Cellular Medicine, published by the CELLULAR & MOLECULAR BIOLOGY RESEARCH CENTER in Iran, is a leading platform dedicated to advancing research in various domains of molecular and cellular sciences. With an ISSN of 2251-9637 and E-ISSN 2251-9645, this journal features a rigorous peer-review process that ensures the publication of high-quality, impactful research. Spanning from 2016 to 2024, it is categorized in the third quartile (Q3) in Biochemistry, Cell Biology, Genetics, and Molecular Biology, and second quartile (Q2) in Biotechnology, underlining its significance in the scientific community. Although currently non-open access, it maintains credible visibility through Scopus rankings, reflecting its importance in fields such as Biochemistry, Molecular Medicine, and Genetics, where it holds respectable ranks and percentiles. This journal aims to foster collaboration and knowledge dissemination among researchers, professionals, and students in the pursuit of enhancing understanding and innovation in molecular and cellular medicine.

Cell Communication and Signaling

Fostering Global Collaboration in Cellular Research
Publisher: BMCISSN: Frequency: 1 issue/year

Cell Communication and Signaling is a premier peer-reviewed journal published by BMC that has made significant contributions to the fields of biochemistry, cell biology, and molecular biology since its establishment in 2003. As an open access journal, it offers unrestricted access to high-quality research, fostering collaboration and innovation among scientists around the globe. The journal is distinguished by its Q1 ranking in all three relevant categories for 2023, underscoring its critical role in advancing the understanding of cellular communication mechanisms and signaling pathways. Positioned within the United Kingdom, Cell Communication and Signaling has been an invaluable resource for researchers, professionals, and students alike, ensuring that the latest findings are accessible to a diverse range of audiences. With an impressive Scopus ranking—placing it in the top percentiles within its subject areas—this journal continues to set the standard for excellence in the pursuit of understanding complex cellular interactions.

EXPERIMENTAL CELL RESEARCH

Fostering Collaboration in Cell Biology Research
Publisher: ELSEVIER INCISSN: 0014-4827Frequency: 20 issues/year

EXPERIMENTAL CELL RESEARCH is a highly respected journal published by Elsevier Inc, specializing in the dynamic and ever-evolving field of Cell Biology. With an impact factor positioned in the Q2 quartile for 2023, it ranks at the 124th position out of 285 in the Scopus Ranks, indicating a solid reputation among peers in the domains of biochemistry, genetics, and molecular biology. Since its inception in 1950, the journal has contributed significantly to the dissemination of groundbreaking research, providing a platform for studies that explore the nuances of cellular mechanisms, processes, and experimental methodologies. Although the journal currently does not offer open access, its commitment to high-quality, peer-reviewed research continues to attract submissions from leading scientists and scholars across the globe. Researchers, professionals, and students alike will find this journal an invaluable resource for keeping abreast of current developments and innovative breakthroughs in cellular science.

Protein & Cell

Fostering Global Knowledge Exchange in Biochemical Research
Publisher: OXFORD UNIV PRESSISSN: 1674-800XFrequency: 12 issues/year

Protein & Cell, published by Oxford University Press, is a distinguished international journal focusing on cutting-edge research in the fields of biochemistry, biotechnology, cell biology, and drug discovery. This open access journal, active since 2014, is dedicated to disseminating innovative findings that advance our understanding of protein functions and cellular processes, making it an essential resource for researchers, professionals, and students alike. With an impressive 2023 impact factor reflected in its Q1 ranking across multiple categories such as Biochemistry, Drug Discovery, and Cell Biology, 'Protein & Cell' stands at the forefront of scientific research, driving collaboration and discussion in the scientific community. Researchers can access the journal freely online, fostering a global exchange of knowledge and contributing to significant advancements in medicine and biotechnology. Located in the United Kingdom, the journal strives to be a pivotal platform for impactful research that influences future studies and applications.

Stem Cells International

Connecting Researchers to Transform Stem Cell Science
Publisher: HINDAWI LTDISSN: 1687-966XFrequency:

Stem Cells International is a premier open access journal published by HINDAWI LTD, focusing on the rapidly evolving field of stem cell research. With an ISSN of 1687-966X and E-ISSN 1687-9678, this journal has been a vital resource since its inception in 2010, showcasing innovative studies and breakthroughs up to 2024. Positioned in Q3 in Cell Biology and Q2 in Molecular Biology for 2023, as well as well-ranked in the Scopus database, the journal serves as an essential platform for researchers, professionals, and students dedicated to exploring the implications of stem cell technology in regenerative medicine and biological research. The open access model ensures wide accessibility, fostering collaboration and knowledge-sharing across the scientific community, making it a cornerstone in advancing the understanding and application of stem cell science.

Cell Discovery

Leading the Charge in Cell Biology Research
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

Cell Discovery, published by SPRINGERNATURE, is a premier open access journal in the dynamic fields of Biochemistry, Cell Biology, Genetics, and Molecular Biology. Since its inception in 2015, this journal has established itself as a key platform for disseminating high-impact research and is recognized with a Q1 ranking across all its core categories for the year 2023. With its remarkable Scopus rankings—7th in Genetics, 9th in Biochemistry, 13th in Molecular Biology, and 15th in Cell Biology—Cell Discovery positions itself among the elite journals in life sciences, showcasing the most innovative breakthroughs and comprehensive reviews. Based in the United Kingdom, this journal operates under an open access model, ensuring that groundbreaking discoveries are readily available to researchers, professionals, and students around the globe. With a commitment to advancing scientific knowledge, Cell Discovery welcomes contributions that push the frontiers of our understanding in cellular and genetic sciences.

CELLULAR & MOLECULAR BIOLOGY LETTERS

Unlocking the Secrets of Life at the Molecular Level
Publisher: BMCISSN: 1425-8153Frequency: 1 issue/year

CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.